| Description |
Our inaugural forum was a great success with more than 170 people in attendance. A key highlight of the program was an interactive panel discussion with government perspectives from prosecutors, legislators and representatives from states with the most challenging laws including Vermont, Maine and Minnesota.
This year, we bring representatives from the boards of pharmacy in West Virginia, Nevada and Washington, DC to the forum to discuss current and pending state laws requiring spend tracking or reporting.
Topics also being covered in 2008 include:
• Update on Federal Physician Payment Sunshine Act
• Internal Collaborative Strategies to Manage Non-Promotional Spend
• Overcoming Challenges with Collecting Third-Party Vendor Data
• Development of an Auditing and Monitoring Program
• Use Reported Information to Capitalize on Cost Savings
Come with your team members! Sessions focus on how Compliance teams work with colleagues in Medical Affairs, Marketing, Managed Markets, Finance and others to ensure appropriate aggregate spend tracking and reporting.
Plus!
Participate in an Extended Session with Break-Outs Led by Novartis Pharmaceutical Corporation to Benchmark Against Peers on Aggregate Spend Program Implementation!
|
|
